Novo Nordisk AS (HAM:NOVA)
€ 41.8 -0.20 (-0.48%) Market Cap: 185.04 Bil Enterprise Value: 201.74 Bil PE Ratio: 11.60 PB Ratio: 6.95 GF Score: 81/100

Q1 2025 Novo Nordisk A/S Earnings Presentation (London-Based Investors) Transcript

May 8, 2025 / 12:15 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NOVOb.CO - Novo Nordisk A/S
Q1 2025 Novo Nordisk A/S Earnings Presentation (London-Based Investors)
May 08, 2025 / 12:15PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome everyone. My name is Thibu Guha. I'm a pharmacqui analyst at Morgan Stanley. So thanks for joining the Novo first quarter 225, event post results. We are delighted to have with us, the management team of our disk.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
So.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
Las Frergensen, Captain Ntson, Martin Lange, and Mike Gustav. So thank you very
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot